Pubblicazioni

Deprescribing in migraine

2021 - EXPERT OPINION ON DRUG SAFETY

Martelletti, P.; Luciani, M.; Spuntarelli, V.; Bentivegna, E.

Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study

2021 - EXPERT OPINION ON DRUG SAFETY

Pugliese, N.; Giorgini, A.; Maggi, D.; Capogreco, A.; Dibenedetto, C.; Lubrano Lobianco, F.; Dal Buono, A.; Monico, S.; Meli, R.; Battezzati, P. M.; Lleo, A.; De Santis, A.; Zuin, M.; Aghemo, A.

Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia

2021 - EXPERT OPINION ON DRUG SAFETY

Panzuto, F.; Magi, L.; Rinzivillo, M.

Efficacy and safety of PCSK9 monoclonal antibodies

2019 - EXPERT OPINION ON DRUG SAFETY

Iqbal, Z.; Dhage, S.; Mohamad, J. B.; Abdel-Razik, A.; Donn, R.; Malik, R.; Ho, J. H.; Liu, Y.; Adam, S.; Isa, B.; Stefanutti, C.; Soran, H.

The safety of available treatments options for neuroendocrine tumors

2017 - EXPERT OPINION ON DRUG SAFETY

Faggiano, A.; Lo Calzo, F.; Pizza, G.; Modica, R.; Colao, A.